ASQ Certified Biomedical Auditor (CBA) Practice Test
ASQ Certified Biomedical Auditor (CBA) के लिए अपना आत्मविश्वास बढ़ाएँ। अवधारणाओं का अभ्यास करें, उत्तरों को समझें और हर सवाल के साथ अपना ज्ञान मज़बूत करें।
एक नमूना सवाल आज़माएँपरीक्षा का परिचय और विवरण
The ASQ Certified Biomedical Auditor (CBA) certification is a globally recognized credential that validates an individual's expertise in auditing biomedical systems against regulatory requirements and quality standards. This certification demonstrates comprehensive knowledge of auditing principles, biomedical device regulations (including FDA 21 CFR Part 820 and ISO 13485), risk management (ISO 14971), and the entire quality management system lifecycle. CBAs are qualified to conduct independent, objective audits of biomedical processes, suppliers, and design controls, ensuring compliance and driving continuous improvement in medical device and diagnostic organizations. Earning this credential signifies mastery of the technical knowledge and professional judgment required to assess regulatory compliance, identify systemic issues, and contribute to patient safety and product efficacy. The CBA is a mark of distinction for professionals seeking to advance in regulatory affairs, quality assurance, and compliance roles within the highly regulated biomedical industry.
नमूना प्रश्न
अभ्यास कैसे काम करता है, यह जानने के लिए एक उत्तर चुनें और व्याख्या देखें।
A manufacturer of a dental curing light distributes in the United States and EU. In November 2026, an auditor at a printed-label supplier in Mexico samples lot L2476 and finds a gap involving nonconforming product; the product passed final inspection and no injury complaint has been confirmed. What is the most defensible audit conclusion or next step?
An audit team is on day 2 at a software maintenance team in California reviewing IVD reagent cartridge. Records for lot L2421 show a recent process change, two late CAPAs, and an unrelated warehouse temperature alarm that did not affect this product. The next planned topic is logistics. What should the auditor do to keep the audit valid and useful?
A manufacturer of a hemodialysis tubing set distributes in the United States and EU. In June 2026, an auditor at a design center in Minnesota samples lot L2459 and finds a gap involving management responsibility; the product passed final inspection and no injury complaint has been confirmed. What is the most defensible audit conclusion or next step?
A manufacturer of a hemodialysis tubing set distributes in the United States and EU. In February 2026, an auditor at a printed-label supplier in Mexico samples lot L2449 and finds a gap involving 21 CFR Part 821; the product passed final inspection and no injury complaint has been confirmed. What is the most defensible audit conclusion or next step?
A manufacturer of a dental curing light distributes in the United States and EU. In August 2026, an auditor at a printed-label supplier in Mexico samples lot L2446 and finds a gap involving 21 CFR Part 803; the product passed final inspection and no injury complaint has been confirmed. What is the most defensible audit conclusion or next step?
करियर के अवसर और वेतन
जब तक लोकल रेंज न दिखे, ये US मार्केट के आंकड़े हैं।